Your browser doesn't support javascript.
loading
Reimbursed Medication Adherence Enhancing Interventions in European Countries: Results of the EUREcA Study.
Ágh, Tamás; Hadziabdic, Maja Ortner; Garuoliene, Kristina; Granas, Anne Gerd; Aarnio, Emma; Menditto, Enrica; Gregório, João; Barnestein-Fonseca, Pilar; Mevsim, Vildan; Kardas, Przemyslaw.
Afiliação
  • Ágh T; Syreon Research Institute, Budapest, Hungary.
  • Hadziabdic MO; Center for Health Technology Assessment and Pharmacoeconomic Research, University of Pécs, Pécs, Hungary.
  • Garuoliene K; Centre for Applied Pharmacy, Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia.
  • Granas AG; Pharmacy Center, Institute of Biomedical Science, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
  • Aarnio E; Section for Pharmaceutics and Social Pharmacy, Department of Pharmacy, University of Oslo, Oslo, Norway.
  • Menditto E; Norwegian Centre for E-health Research, University Hospital of North Norway, Tromsø, Norway.
  • Gregório J; School of Pharmacy, University of Eastern Finland, Kuopio, Finland.
  • Barnestein-Fonseca P; CIRFF, Center of Pharmacoeconomics and Drug Utilization Research, Department of Pharmacy University of Naples Federico II, Naples, Italy.
  • Mevsim V; CBIOS, Universidade Lusófona's Research Center for Biosciences & Health Technologies, Lisboa, Portugal.
  • Kardas P; CUDECA Institute for Training and Research in Palliative Care, CUDECA Hospice Foundation, Málaga, Spain.
Front Pharmacol ; 13: 892240, 2022.
Article em En | MEDLINE | ID: mdl-35784711

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Health_technology_assessment / Prognostic_studies / Qualitative_research / Risk_factors_studies Idioma: En Revista: Front Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Hungria País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Health_technology_assessment / Prognostic_studies / Qualitative_research / Risk_factors_studies Idioma: En Revista: Front Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Hungria País de publicação: Suíça